600721 百花医药
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)3.3121.889-5.1579.200-40.630
总资产报酬率 ROA (%)2.1881.257-3.5056.114-28.224
投入资产回报率 ROIC (%)2.6821.551-4.2877.646-35.761

边际利润分析
销售毛利率 (%)46.46549.03739.91840.039-161.954
营业利润率 (%)9.3394.862-8.78622.584-438.647
息税前利润/营业总收入 (%)8.9744.229-9.25822.061-353.334
净利润/营业总收入 (%)8.2423.513-9.92821.281-378.283

收益指标分析
经营活动净收益/利润总额(%)201.896413.100-82.17354.05573.178
价值变动净收益/利润总额(%)9.46411.860-0.0340.707-2.330
营业外收支净额/利润总额(%)-0.330-8.9464.282-2.197-17.458

偿债能力分析
流动比率 (X)1.8151.8311.7491.8441.429
速动比率 (X)1.4581.4261.2321.0790.818
资产负债率 (%)34.35433.46433.41030.13935.962
带息债务/全部投入资本 (%)14.72612.72811.98410.95512.088
股东权益/带息债务 (%)544.472642.967687.595765.453680.754
股东权益/负债合计 (%)191.091198.825199.308230.123176.670
利息保障倍数 (X)-26.876-18.028117.429-581.341-17.565

营运能力分析
应收账款周转天数 (天)22.13217.45119.09225.494547.610
存货周转天数 (天)213.612262.317294.099408.022345.723